Financhill
Buy
68

PASG Quote, Financials, Valuation and Earnings

Last price:
$10.10
Seasonality move :
20.53%
Day range:
$8.23 - $9.31
52-week range:
$5.12 - $20.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.92x
Volume:
91.7K
Avg. volume:
41.7K
1-year change:
-35.14%
Market cap:
$28.7M
Revenue:
--
EPS (TTM):
-$9.75

Earnings Data

Next earnings date for PASG
Mar 03
2026
Most recent earnings per share
-$2.44
Beat by $0.53
(Nov 10/2025)
Consensus Estimate
-$2.97
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PASG Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/03/2026 Q4 -- -- -- -$2.80 --
11/10/2025 Q3 -- -- -$2.44 -$2.97 $0.53
08/12/2025 Q2 -- -- -$2.96 -$4.15 $1.19
05/13/2025 Q1 -- -- -$0.25 -$4.47 $4.22
03/04/2025 Q4 -- -- -$4.10 -$4.00 -$0.10
11/13/2024 Q3 $2M -- -$0.31 -$4.67 $4.35
08/08/2024 Q2 -- -- -$0.26 -$6.20 $5.94
05/14/2024 Q1 -- -- -$0.30 -$6.90 $6.60
03/04/2024 Q4 -- -- -$0.31 -$8.00 $7.70
11/13/2023 Q3 -- -- -$0.49 -$8.80 $8.31
08/07/2023 Q2 -- -- -$0.44 -- --
05/11/2023 Q1 -- -- -$0.63 -- --
03/06/2023 Q4 -- -- -$0.50 -- --
11/10/2022 Q3 -- -- -$0.49 -- --
08/04/2022 Q2 -- -- -$0.73 -- --
05/16/2022 Q1 -- -- -$0.79 -- --
03/03/2022 Q4 -- -- -$0.95 -- --
11/04/2021 Q3 -- -- -$0.87 -- --
08/05/2021 Q2 -- -- -$0.90 -- --
05/05/2021 Q1 -- -- -$0.76 -- --
03/03/2021 Q4 -- -- -$0.85 -- --
11/10/2020 Q3 -- -- -$0.63 -- --
08/13/2020 Q2 -- -- -$0.60 -- --
05/11/2020 Q1 -- -- -$1.00 -- --
12/31/2019 Q4 -- -- -$0.29 -- --
09/30/2019 Q3 -- -- -$9.50 -- --
06/30/2019 Q2 -- -- -$0.29 -- --
03/31/2019 Q1 -- -- -$6.40 -- --
12/31/2018 Q4 -- -- -$0.13 -- --

Passage Bio, Inc. Earnings Questions

  • How Much did Passage Bio, Inc. Generate in Revenue Last Quarter?

    Passage Bio, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Passage Bio, Inc. Beat Earnings Last Quarter?

    Passage Bio, Inc. announced earnings per share of -$2.44 which represents a beat of analyst forecast a -$2.97 per share.

  • Is Passage Bio, Inc. Profitable?

    Passage Bio, Inc. reported -$200K that represents -$0.06 per share over the last quarter.

  • What is the Analyst Consensus for Passage Bio, Inc. EPS Next Year?

    Passage Bio, Inc.'s earnings are forecast to decrease from -$21.44 per share to -$16.50 per share next year representing a decrease of -47.92%.

  • When is Passage Bio, Inc.'s Earnings Date?

    Passage Bio, Inc.'s next earnings date is March 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 7.35% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 47.5% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 10.15% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock